Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
If you have or previously had thyroid disease
If a supplement has low bioavailability, even a massive 1000 mg dose might result in very little actual benefit
Review this guide for realistic timelines
The biggest discount on BIOptimizers' extensive range of wellness products, along with amazing gifts with purchase, is available *exclusively* on my page
Works amazing, helps so much
US$ 21.88
US$ 22.63
US$ 28.77
